Thursday, 9 May 2019

Indivior signs deal to sell schizophrenia drug in Canada

British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)